cached image

Chih-Pin(Max) Chuu, PhD - Publications

Institute of Cellular and Systems Biology Taiwan National Health Research Institutes 
Prostate Cancer, Protein mechanisms of bioactive natural products,

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Jim WT, Chiu NC, Ho CS, Shu CH, Chang JH, Hung HY, Kao HA, Chang HY, Peng CC, Yui BH, Chuu CP. Outcome of Preterm Infants With Postnatal Cytomegalovirus Infection via Breast Milk: A Two-Year Prospective Follow-Up Study. Medicine. 94: e1835. PMID 26512588 DOI: 10.1097/MD.0000000000001835  0.68
2015 Kao HY, Wu WH, Liang TY, Lee KT, Hou MF, Shi HY. Cloud-Based Service Information System for Evaluating Quality of Life after Breast Cancer Surgery. Plos One. 10: e0139252. PMID 26422018 DOI: 10.1371/journal.pone.0139252  0.68
2015 Huang JH, Lin CY, Wu SY, Chen WY, Chu CL, Brown GD, Chuu CP, Wu-Hsieh BA. CR3 and Dectin-1 Collaborate in Macrophage Cytokine Response through Association on Lipid Rafts and Activation of Syk-JNK-AP-1 Pathway. Plos Pathogens. 11: e1004985. PMID 26132276 DOI: 10.1371/journal.ppat.1004985  0.68
2015 Chang YT, Shu CL, Lai JY, Ching-Yu L, Chuu CP, Morishita K, Ichikawa T, Jessberger R, Fukui Y. SWAP-70 contributes to spontaneous transformation of mouse embryo fibroblasts. Experimental Cell Research. PMID 26103139 DOI: 10.1016/j.yexcr.2015.06.011  0.68
2015 Kuo YY, Jim WT, Su LC, Chung CJ, Lin CY, Huo C, Tseng JC, Huang SH, Lai CJ, Chen BC, Wang BJ, Chan TM, Lin HP, Chang WS, Chang CR, ... Chuu CP, et al. Caffeic Acid Phenethyl Ester Is a Potential Therapeutic Agent for Oral Cancer. International Journal of Molecular Sciences. 16: 10748-10766. PMID 25984601 DOI: 10.3390/ijms160510748  0.68
2015 Wen HC, Chuu CP, Chen CY, Shiah SG, Kung HJ, King KL, Su LC, Chang SC, Chang CH. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells. Plos One. 10: e0125518. PMID 25928539 DOI: 10.1371/journal.pone.0125518  0.68
2015 Lin HP, Chan TM, Fu RH, Chuu CP, Chiu SC, Tseng YH, Liu SP, Lai KC, Shih MC, Lin ZS, Chen HS, Yeh DC, Lin SZ. Applicability of adipose-derived stem cells in type 1 diabetes mellitus. Cell Transplantation. 24: 521-32. PMID 25621468 DOI: 10.3727/096368915X686977  0.68
2015 Chung CJ, Chang CH, Chuu CP, Yang CR, Chang YH, Huang CP, Chen WC, Chung MC, Chang H. Reduced 5-methylcytosine level as a potential progression predictor in patients with T1 or non-invasive urothelial carcinoma. International Journal of Molecular Sciences. 16: 677-90. PMID 25561224 DOI: 10.3390/ijms16010677  0.68
2015 Lin HP, Lin CY, Huo C, Jan YJ, Tseng JC, Jiang SS, Kuo YY, Chen SC, Wang CT, Chan TM, Liou JY, Wang J, Wayne Chang WS, Chang CH, Kung HJ, ... Chuu CP, et al. AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf & TSC1/TSC2 Oncotarget. 6: 27097-27112. DOI: 10.18632/oncotarget.4553  0.68
2015 Huo C, Kao YH, Chuu CP. Androgen receptor inhibits epithelial-mesenchymal transition, migration, and invasion of PC-3 prostate cancer cells Cancer Letters. DOI: 10.1016/j.canlet.2015.08.001  0.68
2015 Lin HP, Lin CY, Huo C, Hsiao PH, Su LC, Jiang SS, Chan TM, Chang CH, Chen LT, Kung HJ, Wang HD, Chuu CP. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1 Oncotarget. 6: 6684-6707.  0.68
2014 Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2. Plos One. 9: e109170. PMID 25271736 DOI: 10.1371/journal.pone.0109170  0.68
2014 Chan TM, Harn HJ, Lin HP, Chiu SC, Lin PC, Wang HI, Ho LI, Chuu CP, Chiou TW, Hsieh AC, Chen YW, Ho WY, Lin SZ. The use of ADSCs as a treatment for chronic stroke. Cell Transplantation. 23: 541-7. PMID 24816449 DOI: 10.3727/096368914X678409  0.68
2014 Chuang CH, Wang WJ, Li CF, Ko CY, Chou YH, Chuu CP, Cheng TL, Wang JM. The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer. Cell Death & Disease. 5: e1220. PMID 24810056 DOI: 10.1038/cddis.2014.106  0.68
2014 Leung KK, Hause RJ, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome. Molecular & Cellular Proteomics : McP. 13: 1705-23. PMID 24728074 DOI: 10.1074/mcp.M113.034876  0.68
2014 Fang WT, Fan CC, Li SM, Jang TH, Lin HP, Shih NY, Chen CH, Wang TY, Huang SF, Lee AY, Liu YL, Tsai FY, Huang CT, Yang SJ, Yen LJ, ... Chuu CP, et al. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma. International Journal of Cancer. Journal International Du Cancer. 135: 809-19. PMID 24477565 DOI: 10.1002/ijc.28734  0.68
2014 Kokontis JM, Lin HP, Jiang SS, Lin CY, Fukuchi J, Hiipakka RA, Chung CJ, Chan TM, Liao S, Chang CH, Chuu CP. Correction: Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2 (PLoS ONE (2014) 9, 10 (e109170) DOI: 10.1371/journal.pone.0109170) Plos One. 9. DOI: 10.1371/journal.pone.0111731  0.68
2013 Lin HP, Lin CY, Hsiao PH, Wang HD, Sheng Jiang S, Hsu JM, Jim WT, Chen M, Kung HJ, Chuu CP. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells. Plos One. 8: e82625. PMID 24349321 DOI: 10.1371/journal.pone.0082625  0.68
2013 Wang SW, Wang SS, Wu DC, Lin YC, Ku CC, Wu CC, Chai CY, Lee JN, Tsai EM, Lin CL, Yang RC, Ko YC, Yu HS, Huo C, Chuu CP, et al. Androgen receptor-mediated apoptosis in bovine testicular induced pluripotent stem cells in response to phthalate esters. Cell Death & Disease. 4: e907. PMID 24201806 DOI: 10.1038/cddis.2013.420  0.68
2013 Lin CY, Huo C, Kuo LK, Hiipakka RA, Jones RB, Lin HP, Hung Y, Su LC, Tseng JC, Kuo YY, Wang YL, Fukui Y, Kao YH, Kokontis JM, Yeh CC, ... ... Chuu CP, et al. Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. Plos One. 8: e65734. PMID 23785446 DOI: 10.1371/journal.pone.0065734  0.68
2013 Kuo YY, Lin HP, Huo C, Su LC, Yang J, Hsiao PH, Chiang HC, Chung CJ, Wang HD, Chang JY, Chen YW, Chuu CP. Caffeic Acid Phenethyl Ester Suppresses Proliferation and Survival of TW2.6 Human Oral Cancer Cells via Inhibition of Akt Signaling. International Journal of Molecular Sciences. 14: 8801-17. PMID 23615471 DOI: 10.3390/ijms14058801  0.68
2013 Shu CL, Jing-Yang-Lai, Su LC, Chuu CP, Fukui Y. SWAP-70: a new type of oncogene. Plos One. 8: e59245. PMID 23555004 DOI: 10.1371/journal.pone.0059245  0.68
2013 Yeh CC, Hsi SC, Chuu CP, Kao YH. Synchronous triple carcinoma of the colon and rectum. World Journal of Surgical Oncology. 11: 66. PMID 23497155 DOI: 10.1186/1477-7819-11-66  0.68
2013 Lin HP, Lin CY, Liu CC, Su LC, Huo C, Kuo YY, Tseng JC, Hsu JM, Chen CK, Chuu CP. Caffeic Acid phenethyl ester as a potential treatment for advanced prostate cancer targeting akt signaling. International Journal of Molecular Sciences. 14: 5264-83. PMID 23466879 DOI: 10.3390/ijms14035264  0.68
2013 Liu CC, Hsu JM, Kuo LK, Chuu CP. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer. Medical Hypotheses. 80: 617-9. PMID 23462369 DOI: 10.1016/j.mehy.2013.02.003  0.68
2012 Hause RJ, Leung KK, Barkinge JL, Ciaccio MF, Chuu CP, Jones RB. Comprehensive binary interaction mapping of SH2 domains via fluorescence polarization reveals novel functional diversification of ErbB receptors. Plos One. 7: e44471. PMID 22973453 DOI: 10.1371/journal.pone.0044471  0.68
2012 Chuu CP, Lin HP, Ciaccio MF, Kokontis JM, Hause RJ, Hiipakka RA, Liao S, Jones RB. Caffeic acid phenethyl ester suppresses the proliferation of human prostate cancer cells through inhibition of p70S6K and Akt signaling networks. Cancer Prevention Research (Philadelphia, Pa.). 5: 788-97. PMID 22562408 DOI: 10.1158/1940-6207.CAPR-12-0004-T  0.68
2012 Lin HP, Jiang SS, Chuu CP. Caffeic acid phenethyl ester causes p21 induction, Akt signaling reduction, and growth inhibition in PC-3 human prostate cancer cells. Plos One. 7: e31286. PMID 22347457 DOI: 10.1371/journal.pone.0031286  0.68
2012 Lin HP, Kuo LK, Chuu CP. Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells. Phytotherapy Research : Ptr. 26: 122-6. PMID 21567511 DOI: 10.1002/ptr.3523  0.68
2012 Chuu CP, Lin HP, Su LC, Lin CY, Huo C, Kuo YY, Chu SC. Targeting Akt signaling for treatment of advanced prostate cancer cells with caffeic acid phenethyl ester Prostate Cancer Cells: Detection, Growth and Treatment. 57-71.  0.68
2011 Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Su LC. Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer. Journal of Biomedical Science. 18: 63. PMID 21859492 DOI: 10.1186/1423-0127-18-63  0.68
2011 Chuu CP, Kokontis JM, Hiipakka RA, Fukuchi J, Lin HP, Lin CY, Huo C, Huo C, Su LC, Liao S. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc. Cancer Science. 102: 2022-8. PMID 21781227 DOI: 10.1111/j.1349-7006.2011.02043.x  0.68
2011 Chuu CP. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer. Medical Hypotheses. 76: 697-9. PMID 21333456 DOI: 10.1016/j.mehy.2011.01.037  0.68
2010 Chuu CP, Lin HP. Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines. Anticancer Research. 30: 3643-8. PMID 20944148  0.68
2010 Ciaccio MF, Wagner JP, Chuu CP, Lauffenburger DA, Jones RB. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nature Methods. 7: 148-55. PMID 20101245 DOI: 10.1038/nmeth.1418  0.68
2009 Chuu CP, Chen RY, Kokontis JM, Hiipakka RA, Liao S. Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells. Cancer Letters. 275: 86-92. PMID 18977589 DOI: 10.1016/j.canlet.2008.10.001  0.68
2009 Liao S, Kokontis JM, Chuu CP, Hiipakka RA. Androgen action and modulation of prostate and prostate cancer growth: An historical perspective Androgen Action in Prostate Cancer. 9-55. DOI: 10.1007/978-0-387-69179-4_1  0.68
2008 Chuu CP, Chen RY, Barkinge JL, Ciaccio MF, Jones RB. Systems-level analysis of ErbB4 signaling in breast cancer: a laboratory to clinical perspective. Molecular Cancer Research : McR. 6: 885-91. PMID 18567793 DOI: 10.1158/1541-7786.MCR-07-0369  0.68
2007 Chuu CP, Chen RY, Hiipakka RA, Kokontis JM, Warner KV, Xiang J, Liao S. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. Biochemical and Biophysical Research Communications. 357: 341-6. PMID 17416342 DOI: 10.1016/j.bbrc.2007.03.116  0.68
2007 Chuu CP, Kokontis JM, Hiipakka RA, Liao S. Modulation of liver X receptor signaling as novel therapy for prostate cancer. Journal of Biomedical Science. 14: 543-53. PMID 17372849 DOI: 10.1007/s11373-007-9160-8  0.68
2006 Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY, Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Research. 66: 6482-6. PMID 16818617 DOI: 10.1158/0008-5472.CAN-06-0632  0.68
2005 Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S. Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity. The Prostate. 65: 287-98. PMID 16015608 DOI: 10.1002/pros.20285  0.68
2005 Chuu CP, Hiipakka RA, Fukuchi J, Kokontis JM, Liao S. Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice. Cancer Research. 65: 2082-4. PMID 15781616 DOI: 10.1158/0008-5472.CAN-04-3992  0.68
2004 Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Research. 64: 7686-9. PMID 15520170 DOI: 10.1158/0008-5472.CAN-04-2332  0.68
Show low-probability matches.